Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Teewinot Life Sciences logo — Teewinot is a global leader in the biosynthetic development...

Teewinot Life Sciences

Teewinot is a global leader in the biosynthetic development and production of cannabinoids and their derivatives.

Founded 2009 United States Tampa, United States 2 employees Series B Total: $19.30M Biotechnology, Pharmaceutical

General Information

Company Name Teewinot Life Sciences
Founded Year 2009
Location United States Tampa, United States
Employees 2
Industries Biotechnology, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Teewinot Life Sciences. To contact Teewinot Life Sciences, visit tlscorp.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Teewinot Life Sciences compare?

A PDF of Teewinot Life Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Teewinot Life Sciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Teewinot Life Sciences

Teewinot Life Sciences is a global leader in the biosynthetic development and production of cannabinoids and their derivatives. The company, founded in 2015 and headquartered in the United States, focuses on the biosynthetic production of naturally-occurring cannabinoids and cannabinoid prodrugs. Teewinot currently manufactures kilogram quantities of 18 different naturally-occurring cannabinoids, as well as numerous cannabinoid prodrugs, all in pharmaceutically pure form. The company's last investment was a significant $12.30M Series B investment made on 01 May 2017, with the investment coming from Tuatara Capital, demonstrating strong investor confidence in the company's potential. Teewinot's dedication to producing high-quality cannabinoids and their derivatives positions it as a promising player in the biotechnology and pharmaceutical industries, with substantial growth prospects in the market.

Business keywords: biosynthetic development, cannabinoids, cannabinoid production, pharmaceutical manufacturing, global market, innovation, drug development, prodrugs, pharmaceutically pure, cannabinoid derivatives

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $12.30M 1
Tuatara Capital
Tuatara Capital
01 May 2017
Series A $7.00M 1
Tuatara Capital
Tuatara Capital
01 Dec 2015

Teewinot Life Sciences Alternatives & Competitors

View All Alternatives
Teewinot Life Sciences vs
Nordmark Pharma GmbH
Nordmark Pharma GmbH Germany

Full Solution Partner für biopharmazeutische Wirkstoffe und Arzneimittel

264 employees
Biotechnology, Food and Beverage
Teewinot Life Sciences vs
Bostal Drug Delivery
Bostal Drug Delivery

Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals sinc...

Series B
Biotechnology, Health Care
Teewinot Life Sciences vs
Escientia Life Sciences
Escientia Life Sciences United States

We are a leading development and manufacturing partner to innovative pharmaceuticals and biotechnolo...

104 employees
Biotechnology, Manufacturing
View all alternatives

FAQ About Teewinot Life Sciences

Teewinot is a global leader in the biosynthetic development and production of cannabinoids and their derivatives.
Teewinot Life Sciences was founded in 2009.
Teewinot Life Sciences is headquartered in Tampa, United States.
Teewinot Life Sciences operates in Biotechnology and Pharmaceutical. Its work centres on biosynthetic development, cannabinoids, cannabinoid production and pharmaceutical manufacturing.
Teewinot Life Sciences has approximately 2 employees.
Teewinot Life Sciences has completed 2 funding rounds, raising a total of $19.30M. The latest funding stage is Series B.
Top alternatives and competitors to Teewinot Life Sciences include Nordmark Pharma GmbH, Bostal Drug Delivery, Escientia Life Sciences, Celadon Pharmaceuticals, Oxford Cannabinoid Technologies Holdings Plc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Teewinot Life Sciences and Nordmark Pharma GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Teewinot Life Sciences, https://bouncewatch.com/company/teewinot-life-sciences, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout